The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.
about
Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemiaAcute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseAlternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: BloodReduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignanciesHLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.Use of biological assignment in hematopoietic stem cell transplantation clinical trials.Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.Acute myeloid leukaemia in the elderly: a review.Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.How to manage high-risk acute myeloid leukemia.Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensusTreatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.Recent developments in management of older patients with acute myeloid leukemia.Treatment of acute myeloid leukemia in the elderly.The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo.Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey.Redefining transplant in acute leukemia.Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective sAllogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity.Older Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions.Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation.A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.
P2860
Q26744283-E3C4DFB6-D98A-44A9-9E5E-9970B225FA0AQ27851694-0A46FFD6-1A3B-4ED5-9C50-40E013AC1ECFQ33835099-5F039ED9-BBDE-42EE-884B-5E422DFA7B01Q33859061-5BA0BB14-D6F2-4B18-A886-E368A189F6D3Q33990856-9814E66A-ECC2-4584-A16E-BF319E9FE4B2Q34217884-0A033D48-4EBA-4F9B-8051-20C981AB8783Q34463645-6267BE80-03DD-403A-AFFC-2E01125313D9Q34572795-A7CB9CEF-02EC-495B-8937-D3DDD8B0ADD9Q34630588-16847A2B-7783-4AD7-BD2E-445E164C86C3Q35800814-582EAA09-BE57-42D4-8403-C11B32DCB944Q36548358-36483EC8-E750-4F9F-AC81-4D9D87A2D0A4Q37061964-E392DBD8-1D18-44F0-9CD5-29D2A2C0D386Q37148409-7E08BF07-EEF7-4289-95BF-8EF0D3A8384CQ37163399-6ACB3B9A-132D-4114-9AA6-2FB37E5FBE6EQ37267762-086E3CC8-7CAA-4DDB-AC7B-55940A82578AQ37337422-E0BE20E2-2663-47F5-BA5E-415E316CB74FQ37718826-DB2105B8-CF30-489C-AD1B-E09C05026514Q37840260-0B3B18DE-9FC6-4E56-A914-BAC42B9F4E90Q37842488-B1151896-86D1-4F70-8413-AB1FDBE4BF5BQ37942816-0A8D608B-3F02-41F6-BCC9-E34BA8F80717Q37960820-7E556E50-F7FC-430B-85EE-79527B24E6BAQ38106983-57D54302-2638-4565-BA1D-375AE2CB072CQ38176519-792CFC9C-30F4-4987-B455-FE67F07DB91CQ38248427-7D1A6285-F32F-431A-BD09-2F2785C069BCQ38488058-35902CCB-27F9-4058-A5A2-1EC0EFF10580Q39002077-B70BCCC4-7833-4A9A-8919-5176555698FAQ39589911-3EA3B65A-3D64-4F46-BDC2-AB26F44EA6B2Q42149211-61020C43-FDE7-4526-A9AD-1F27DA29C00BQ42743023-879B1C8D-9897-4D6D-BC5D-CDF2032B64CBQ42937122-78DF2FF5-2368-42E1-B851-2C1F7AF62DD8Q43582944-DD7A7004-DF9E-4C54-B19D-CD85353ECA36Q44657508-1B84A9C5-3362-4BAE-81F2-C157EBDAA3B7Q45909230-65A577BC-5210-4734-846E-E2D61D97AF2FQ46727249-2B32735C-2325-4D22-A40F-10DDF9AA238CQ46819255-6D795127-DB4E-442B-AE24-73BA27AE66C7Q47146837-120F7154-CB65-44C6-A102-B726CABEB34FQ47770899-C093EA06-9C05-42C6-990D-4DD75B89784FQ47983957-4F6CE2E0-6854-4B10-8CA0-EDFEED16AE40Q48069751-615FC2B3-DE80-4A3B-8F1D-65B5D3F11242Q52898922-ADB372E4-D194-44AB-81F0-2B7187B0DC34
P2860
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The role of reduced intensity ...... donor vs no donor comparison.
@en
The role of reduced intensity ...... donor vs no donor comparison.
@nl
type
label
The role of reduced intensity ...... donor vs no donor comparison.
@en
The role of reduced intensity ...... donor vs no donor comparison.
@nl
prefLabel
The role of reduced intensity ...... donor vs no donor comparison.
@en
The role of reduced intensity ...... donor vs no donor comparison.
@nl
P2093
P2860
P356
P1433
P1476
The role of reduced intensity ...... donor vs no donor comparison.
@en
P2093
Gastaut JA
Ladaique P
de Lavallade H
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403770
P577
2005-06-01T00:00:00Z
P5875
P6179
1020634553